Lyell lays off 25% of staff and CMO leaves as company foreshadows first clinical data next year

Lyell Immunopharma is laying off 25% of its workforce, and its chief medical officer is leaving, according to the Bay Area biotech company’s third-quarter report.

The company had 274 employees as of December of last year. It declined to specify how many workers are part of…
Click here to view original post